An evaluation of an influenza vaccination campaign targeting pregnant women in 27 clinics in two provinces of South Africa, 2015 - 2018.
Influenza vaccines
Pregnant women, South Africa
Vaccination
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
09 Sep 2021
09 Sep 2021
Historique:
received:
18
05
2021
accepted:
31
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
14
9
2021
Statut:
epublish
Résumé
Despite prioritization, routine antenatal influenza vaccine coverage is < 16% in South Africa. We aimed to describe maternal influenza vaccine coverage in 27 antenatal clinics (ANCs) in Gauteng and Western Cape (WC) Provinces, where in collaboration with the Department of Health (DoH), we augmented the annual influenza vaccination programme among pregnant women. From 2015 through 2018, 40,230 additional doses of influenza vaccine were added to the available stock and administered as part of routine antenatal care. Educational talks were given daily and data were collected on women attending ANCs. We compared characteristics of vaccinated and unvaccinated women using multivariable logistic regression. We screened 62,979 pregnant women during the period when Southern Hemisphere influenza vaccines were available (27,068 in Gauteng and 35,911 in WC). Vaccine coverage at the targeted clinics was 78.7% (49,355/62682), although pregnant women in WC were more likely to be vaccinated compared to those in the Gauteng (Odds ratio (OR) =3.7 p < 0.001). Women aged 25-29 and > 35 years were less likely to be vaccinated than women aged 18-24 years (OR = 0.9 p = 0.053; OR = 0.9 p < 0.001). HIV positive status was not associated with vaccination (OR = 1.0 p = 0.266). Reasons for not vaccinating included: vaccine stock-outs where ANCs depleted available stock of vaccines and/or were awaiting delivery of vaccines (54.6%, 6949/12723), refusal/indecision (25.8%, 3285), and current illness that contraindicated vaccination (19.6%, 2489). Antenatal vaccination uptake was likely improved by the increased vaccine supply and vaccine education offered during our campaign.
Identifiants
pubmed: 34503508
doi: 10.1186/s12913-021-06962-8
pii: 10.1186/s12913-021-06962-8
pmc: PMC8427945
doi:
Substances chimiques
Influenza Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
941Informations de copyright
© 2021. The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Clin Exp Immunol. 2019 Feb;195(2):139-152
pubmed: 30422307
N Engl J Med. 2005 Dec 15;353(24):2559-67
pubmed: 16354892
PLoS One. 2019 Aug 1;14(8):e0220705
pubmed: 31369626
Curr Opin Infect Dis. 2017 Oct;30(5):455-462
pubmed: 28777109
Influenza Other Respir Viruses. 2019 Mar;13(2):201-207
pubmed: 30099856
N Engl J Med. 2010 Jan 7;362(1):27-35
pubmed: 20032319
Aust N Z J Obstet Gynaecol. 2015 Apr;55(2):131-7
pubmed: 25557858
Vaccine. 2020 Jun 2;38(27):4288-4297
pubmed: 32389494
Clin Infect Dis. 2015 Oct 1;61(7):1063-70
pubmed: 26060287
Vaccine. 2013 Oct 25;31(45):5281-8
pubmed: 24016814
Lancet. 2009 Aug 8;374(9688):451-8
pubmed: 19643469
N Engl J Med. 2014 Sep 4;371(10):918-31
pubmed: 25184864
PLoS One. 2017 Mar 16;12(3):e0173983
pubmed: 28301593
Wkly Epidemiol Rec. 2012 May 25;87(21):201-16
pubmed: 24340402
Hum Vaccin Immunother. 2017 Jun 3;13(6):1-8
pubmed: 28319453
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
J Infect Dis. 2012 Dec 15;206 Suppl 1:S153-8
pubmed: 23169963
Vaccine. 2019 Jan 3;37(1):25-33
pubmed: 30471956
Vaccine. 2019 Oct 31;37(46):6874-6884
pubmed: 31575494
Lancet Infect Dis. 2016 Sep;16(9):1026-1035
pubmed: 27261067
N Engl J Med. 2000 Jan 27;342(4):225-31
pubmed: 10648763
N Engl J Med. 2008 Oct 9;359(15):1555-64
pubmed: 18799552